CI vs. ELV, HUM, CNC, GSK, BMY, BSX, REGN, VRTX, MDT, and GILD
Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Humana (HUM), Centene (CNC), GSK (GSK), Bristol-Myers Squibb (BMY), Boston Scientific (BSX), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Medtronic (MDT), and Gilead Sciences (GILD). These companies are all part of the "medical" sector.
Elevance Health (NYSE:ELV) and The Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.
Elevance Health has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, The Cigna Group has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.
Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.7%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. The Cigna Group pays out 46.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years and The Cigna Group has increased its dividend for 4 consecutive years.
Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.76%. The Cigna Group's return on equity of 20.62% beat Elevance Health's return on equity.
In the previous week, The Cigna Group had 5 more articles in the media than Elevance Health. MarketBeat recorded 17 mentions for The Cigna Group and 12 mentions for Elevance Health. The Cigna Group's average media sentiment score of 1.09 beat Elevance Health's score of 0.91 indicating that Elevance Health is being referred to more favorably in the media.
Elevance Health has higher earnings, but lower revenue than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.
The Cigna Group received 97 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.86% of users gave The Cigna Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.
89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.0% of The Cigna Group shares are held by institutional investors. 0.4% of Elevance Health shares are held by company insiders. Comparatively, 0.6% of The Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Elevance Health presently has a consensus target price of $587.42, suggesting a potential upside of 7.25%. The Cigna Group has a consensus target price of $366.14, suggesting a potential upside of 8.10%. Given Elevance Health's higher possible upside, analysts clearly believe The Cigna Group is more favorable than Elevance Health.
Summary
Elevance Health beats The Cigna Group on 12 of the 21 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Cigna Group Competitors List
Related Companies and Tools
